Author

J. S. Prabhu

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 4

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 4 Organism:human· 4 Assay:bulk RNA-seq· 3 Research Focus:differential expression· 3 Approach:statistical model· 3 Approach:experimental assay· 2 Research Focus:gene regulatory network inference· 2 Assay:protein sequence· 1

Frequent Co-Authors

A. CE· 3 shared S. Rajarajan· 3 shared M. K. Jolly· 2 shared R. S. Ramesh· 2 shared S. BS· 2 shared S. Patil· 2 shared S. VP· 2 shared V. P. Nimbalkar· 2 shared

Activity by Year

2022-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 34 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

A. CE

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Androgen Receptor driven gene score identifies tumors with Epithelial to Mesenchymal Transition features in triple negative breast cancer

S. Rajarajan, S. VP, A. CE, M. Nair, A. D. Mavetkar, C. M. Naidu, S. Patil, V. P. Nimbalkar, M. Pillai, M. K. Jolly, R. Sabarinathan, R. S. Ramesh, S. BS, J. S. Prabhu

The paper develops an AR-driven gene score to identify tumors with EMT features in triple-negative breast cancer, finding AR high tumors have better clinical outcomes and higher EMT marker expression.

bioRxiv · Feb 21, 2023 · PreprintCancer Biology

BRCA1 expression, its correlation with clinicopathological features and response to neoadjuvant chemotherapy in high grade serous ovarian cancer from an Indian centre

A. Patil, S. Patil, A. CE, S. Rajarajan, V. P. Nimbalkar, U. Amirtham, C. G, S. MN, G. V. Patil, A. Nargund, P. VR, L. Jacob, P. CS, J. S. Prabhu

bioRxiv · Jan 11, 2023 · PreprintCancer Biology

Acquisition of hybrid E/M phenotype associated with increased migration, drug resistance and stemness is mediated by reduced miR-18a levels in ER-negative breast cancer

M. G. Nair, A. D, C. M, S. VP, A. CE, S. Rajarajan, S. Sahoo, G. Mohan, V. S. Jayakumar, R. S. Ramesh, S. BS, M. K. Jolly, T. T. Maliekal, J. S. Prabhu

This study shows that low miR-18a levels in ER-negative breast cancer drive hybrid E/M cell traits linked to migration, drug resistance, and stemness.

bioRxiv · Sep 5, 2022 · PreprintCancer Biology

RICTOR Drives ZFX-mediated Ganglioside Biosynthesis to Promote Breast Cancer Progression.

K. Rajput, M. N. Ansari, S. K. Jha, N. Medatwal, P. Sharma, S. Datta, A. Kar, T. Pani, K. Cholke, K. Rana, A. Khan, G. Mukherjee, S. Deo, J. S. Prabhu, A. Mukhopadhyay, , U. Dasgupta

This study identifies RICTOR's role in regulating ganglioside biosynthesis via ZFX and UGCG, promoting breast cancer progression through EGFR signaling.

bioRxiv · Jan 10, 2022 · PreprintCancer Biology